![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SLC25A37 |
Gene summary for SLC25A37 |
![]() |
Gene information | Species | Human | Gene symbol | SLC25A37 | Gene ID | 51312 |
Gene name | solute carrier family 25 member 37 | |
Gene Alias | HT015 | |
Cytomap | 8p21.2 | |
Gene Type | protein-coding | GO ID | GO:0000041 | UniProtAcc | Q71JB2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
51312 | SLC25A37 | Dong_P5 | Human | Prostate | Tumor | 1.36e-21 | -2.23e-01 | 0.053 |
51312 | SLC25A37 | GSM5353240_PA_PR5254_T1_S15_L001 | Human | Prostate | Tumor | 9.66e-04 | -4.38e-01 | 0.1575 |
51312 | SLC25A37 | GSM5353243_PA_PR5261_T1_S23_L002 | Human | Prostate | Tumor | 1.41e-03 | -3.13e-01 | 0.1545 |
51312 | SLC25A37 | Pat01-B | Human | Stomach | GC | 4.13e-49 | 9.12e-01 | 0.5754 |
51312 | SLC25A37 | Pat02-B | Human | Stomach | GC | 1.25e-25 | 2.95e-01 | 0.0368 |
51312 | SLC25A37 | Pat03-B | Human | Stomach | GC | 3.17e-35 | 6.94e-01 | 0.3693 |
51312 | SLC25A37 | Pat04-B | Human | Stomach | GC | 8.38e-25 | 4.71e-01 | -0.1483 |
51312 | SLC25A37 | Pat05-B | Human | Stomach | GC | 1.96e-04 | 2.35e-01 | -0.0353 |
51312 | SLC25A37 | Pat06-B | Human | Stomach | GC | 2.75e-25 | 3.27e-01 | -0.1961 |
51312 | SLC25A37 | Pat10-B | Human | Stomach | GC | 5.65e-04 | 4.42e-01 | 0.084 |
51312 | SLC25A37 | Pat11-B | Human | Stomach | GC | 2.68e-11 | 3.43e-01 | -0.182 |
51312 | SLC25A37 | Pat12-B | Human | Stomach | GC | 1.44e-07 | 1.81e-01 | 0.0325 |
51312 | SLC25A37 | Pat15-B | Human | Stomach | GC | 2.00e-18 | 4.38e-01 | -0.0778 |
51312 | SLC25A37 | Pat16-B | Human | Stomach | GC | 2.34e-06 | 1.54e-01 | 0.1918 |
51312 | SLC25A37 | Pat17-B | Human | Stomach | GC | 1.37e-03 | 2.38e-01 | 0.3109 |
51312 | SLC25A37 | Pat18-B | Human | Stomach | GC | 7.53e-20 | 4.62e-01 | -0.0432 |
51312 | SLC25A37 | Pat19-B | Human | Stomach | GC | 7.10e-18 | 5.36e-01 | 0.0826 |
51312 | SLC25A37 | Pat22-B | Human | Stomach | GC | 1.09e-28 | 4.13e-01 | -0.1042 |
51312 | SLC25A37 | Pat24-B | Human | Stomach | GC | 4.36e-04 | 2.05e-01 | -0.1184 |
51312 | SLC25A37 | Pat25-A | Human | Stomach | CAG with IM | 1.94e-24 | 3.36e-01 | -0.1648 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00068398 | Breast | Precancer | mitochondrial transport | 45/1080 | 254/18723 | 1.37e-11 | 1.88e-09 | 45 |
GO:19905427 | Breast | Precancer | mitochondrial transmembrane transport | 22/1080 | 102/18723 | 6.38e-08 | 3.80e-06 | 22 |
GO:00550767 | Breast | Precancer | transition metal ion homeostasis | 20/1080 | 138/18723 | 1.28e-04 | 2.24e-03 | 20 |
GO:00550725 | Breast | Precancer | iron ion homeostasis | 12/1080 | 85/18723 | 3.41e-03 | 2.85e-02 | 12 |
GO:00068263 | Breast | Precancer | iron ion transport | 9/1080 | 58/18723 | 5.67e-03 | 4.08e-02 | 9 |
GO:00000412 | Breast | Precancer | transition metal ion transport | 13/1080 | 105/18723 | 7.35e-03 | 4.89e-02 | 13 |
GO:000683913 | Breast | IDC | mitochondrial transport | 51/1434 | 254/18723 | 1.54e-10 | 1.83e-08 | 51 |
GO:199054214 | Breast | IDC | mitochondrial transmembrane transport | 25/1434 | 102/18723 | 1.39e-07 | 7.74e-06 | 25 |
GO:005507613 | Breast | IDC | transition metal ion homeostasis | 23/1434 | 138/18723 | 3.20e-04 | 4.79e-03 | 23 |
GO:000682611 | Breast | IDC | iron ion transport | 11/1434 | 58/18723 | 4.10e-03 | 3.25e-02 | 11 |
GO:005507212 | Breast | IDC | iron ion homeostasis | 14/1434 | 85/18723 | 4.98e-03 | 3.77e-02 | 14 |
GO:000683923 | Breast | DCIS | mitochondrial transport | 51/1390 | 254/18723 | 5.04e-11 | 6.79e-09 | 51 |
GO:199054222 | Breast | DCIS | mitochondrial transmembrane transport | 25/1390 | 102/18723 | 7.63e-08 | 4.45e-06 | 25 |
GO:005507622 | Breast | DCIS | transition metal ion homeostasis | 23/1390 | 138/18723 | 2.04e-04 | 3.27e-03 | 23 |
GO:000682621 | Breast | DCIS | iron ion transport | 11/1390 | 58/18723 | 3.23e-03 | 2.73e-02 | 11 |
GO:005507221 | Breast | DCIS | iron ion homeostasis | 14/1390 | 85/18723 | 3.78e-03 | 3.03e-02 | 14 |
GO:000683910 | Endometrium | AEH | mitochondrial transport | 66/2100 | 254/18723 | 3.55e-11 | 4.96e-09 | 66 |
GO:19905429 | Endometrium | AEH | mitochondrial transmembrane transport | 31/2100 | 102/18723 | 1.29e-07 | 5.97e-06 | 31 |
GO:000683915 | Endometrium | EEC | mitochondrial transport | 67/2168 | 254/18723 | 5.04e-11 | 7.03e-09 | 67 |
GO:199054216 | Endometrium | EEC | mitochondrial transmembrane transport | 31/2168 | 102/18723 | 2.65e-07 | 1.11e-05 | 31 |
Page: 1 2 3 4 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SLC25A37 | SNV | Missense_Mutation | novel | c.509G>A | p.Arg170His | p.R170H | Q9NYZ2 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-EA-A410-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
SLC25A37 | SNV | Missense_Mutation | rs746602617 | c.940N>A | p.Ala314Thr | p.A314T | Q9NYZ2 | protein_coding | deleterious(0.02) | probably_damaging(0.918) | TCGA-3L-AA1B-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SLC25A37 | SNV | Missense_Mutation | c.769G>A | p.Val257Ile | p.V257I | Q9NYZ2 | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-AA-3864-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
SLC25A37 | SNV | Missense_Mutation | c.346C>T | p.Pro116Ser | p.P116S | Q9NYZ2 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AD-6895-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | |
SLC25A37 | SNV | Missense_Mutation | c.535N>T | p.Arg179Trp | p.R179W | Q9NYZ2 | protein_coding | deleterious(0) | possibly_damaging(0.766) | TCGA-CM-6171-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SLC25A37 | SNV | Missense_Mutation | c.403N>A | p.Val135Ile | p.V135I | Q9NYZ2 | protein_coding | tolerated(0.48) | benign(0.022) | TCGA-G4-6302-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SLC25A37 | SNV | Missense_Mutation | rs371477159 | c.614N>C | p.Leu205Pro | p.L205P | Q9NYZ2 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-G4-6588-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SLC25A37 | SNV | Missense_Mutation | novel | c.292G>A | p.Glu98Lys | p.E98K | Q9NYZ2 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-EI-6917-01 | Colorectum | rectum adenocarcinoma | Male | <65 | III/IV | Chemotherapy | 5fluorouracil+oxaciplatina+l-folinian | SD |
SLC25A37 | SNV | Missense_Mutation | novel | c.391N>G | p.Thr131Ala | p.T131A | Q9NYZ2 | protein_coding | tolerated(0.48) | benign(0.038) | TCGA-F5-6814-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
SLC25A37 | SNV | Missense_Mutation | c.781C>A | p.Leu261Ile | p.L261I | Q9NYZ2 | protein_coding | deleterious(0.04) | probably_damaging(0.968) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |